Awards and Recognitions
Onyx Pharmaceuticals and members of its Leadership Team are recognized as leaders in the biotechnology industry. Onyx also receives awards for its overall performance as a company, its contributions to the community and its patient advocacy. Below are some of Onyx's recent achievements:
Multiple Myeloma Research Foundation Recognized Onyx with Collaborator of the Year Award
Onyx Honored at 30th Annual National Organization for Rare Diseases (NORD) Gala
Onyx Pharmaceuticals was honored at the 30th Annual NORD Gala with the Innovations in 2012 Award for the company’s work in bringing a new treatment option to patients with multiple myeloma. The NORD Gala is an annual event held in Washington, D.C. where researchers and others are honored for significant achievements to improve the lives of people with rare diseases. NORD represents the nearly 30 million Americans who suffer from rare diseases.
Onyx Received the Multiple Myeloma Research Foundation Corporate Leadership Award
Onyx received the Multiple Myeloma Research Foundation Corporate Leadership Award in recognition of Onyx’s commitment to advancing therapies for the treatment of multiple myeloma.
Onyx Honored at BayBio Pantheon Awards Ceremony
Onyx was awarded Outstanding Product Award for Kyprolis™ (carfilzomib) for Injection and Outstanding Company at the Northern California BayBio Pantheon Awards. Each year, BayBio presents the DiNA Awards to recognize achievement and honor excellence in the life sciences industry at the Pantheon Awards Ceremony, which brings together Northern California’s life sciences industry leaders to acknowledge the tremendous accomplishments in the industry. In addition to accepting the Outstanding Company Award, former Onyx CEO Dr. Tony Coles presented former Onyx President and CEO , Hollings Renton, with the 2010 Lifetime Achievement Award
Onyx Pharmaceuticals Honored at American Liver Foundation (ALF) Partnership Awards
Presented November 2, 2009 during the American Liver Foundation National Leadership Conference in Boston
The American Liver Foundation (ALF) awarded Onyx and partner Bayer with a 2009 Partnership Award. This prestigious honor is presented in recognition of the outstanding work done in collaboration with the ALF to increase education about liver disease through a grant sponsored by the companies which provide writing, translation and distribution of information in multiple languages, to ultimately reach a broader, multilingual audience.
Onyx Pharmaceuticals Honored at Annual NORD Gala
Presented May 15, 2009 during the National Organization for Rare Disorders (NORD) Annual Gala
Onyx and Bayer were honored at the NORD annual gala for developing and commercializing Nexavar for the treatment of patients with inoperable liver cancer. The NORD Gala is an annual event held in Washington, D.C. where researchers and others are honored for significant achievements to improve the lives of people with rare diseases. NORD represents the nearly 30 million Americans who suffer from rare diseases.